Pessac, France – In a landmark appointment signaling a shift in leadership and a potential acceleration of innovation, Dr. Mélèze Hocini has been named the Director General of the Institut des maladies du rythme cardiaque (IHU Liryc), a leading research institute dedicated to heart rhythm disorders. The appointment, formalized on February 3, 2026, marks a significant moment as Dr. Hocini becomes the first woman to lead the prestigious institute. This move is being widely celebrated as a breakthrough for gender equality in French medical research leadership.
Dr. Hocini, a highly respected cardiologist and researcher, has been with IHU Liryc since its founding in 2011, initially serving as a co-founder. She has been acting as interim Director General since 2025, demonstrating her capabilities and vision for the institute’s future. Her appointment to a four-year term solidifies her position as a driving force in the fight against cardiac arrhythmias, conditions that affect millions worldwide and are a leading cause of stroke and heart failure.
A Career Dedicated to Understanding Heart Rhythm
Dr. Hocini brings over 20 years of experience in catheter ablation procedures to her new role, specializing in the treatment of atrial fibrillation and ventricular fibrillation. She is an Associate Professor at Bordeaux University Hospital, within the Department of Cardiac arrhythmias center in Bordeaux, France. According to her biography on the IHU Liryc website, her research focuses on unraveling the complex mechanisms underlying atrial rhythm disturbances. This deep understanding of the underlying science is expected to be pivotal in guiding the institute’s research agenda.
IHU Liryc, established as a hospital-university institute, brings together research, patient care, and innovation to tackle the challenges posed by heart rhythm disorders. The institute boasts a team of 200 researchers dedicated to understanding and treating conditions like atrial fibrillation and heart failure. The focus extends beyond treatment to include preventative measures, particularly in light of the often-asymptomatic nature of conditions like atrial fibrillation, which can significantly increase the risk of stroke.
The Growing Role of Connected Devices in Cardiac Care
Dr. Hocini’s leadership comes at a time of rapid technological advancement in cardiac care. Recent research highlights the potential of connected medical devices, such as smartwatches with electrocardiogram (ECG) functionality, to improve the detection of atrial fibrillation. While many such devices have faced scrutiny regarding their reliability, some, backed by institutional research teams, are demonstrating promising results. A study conducted by the Amsterdam University Medical Center (Netherlands) evaluated a smartwatch with ECG capabilities, showcasing the potential for these technologies to play a crucial role in early detection and intervention.
The ability to detect atrial fibrillation early is critical, as it allows for timely intervention to reduce the risk of stroke and heart failure. The challenge lies in identifying reliable devices and integrating them effectively into clinical practice. Dr. Hocini’s expertise and leadership will be instrumental in navigating this evolving landscape and ensuring that patients benefit from the latest advancements in technology.
Breaking Barriers and Inspiring Future Leaders
Dr. Hocini’s appointment is not only a testament to her professional achievements but also a significant step towards greater gender equality in leadership positions within the medical field. As reported by Sud Ouest, her rise to the directorship challenges the historical imbalance in representation at the highest levels of medical institutions. She acknowledges the systemic issues that have historically limited opportunities for women in leadership, stating that a reversal of the gender imbalance should be just as noteworthy as the imbalance itself.
This sentiment underscores the importance of creating a more inclusive and equitable environment within medical research and healthcare. Dr. Hocini’s success serves as an inspiration to aspiring female scientists and clinicians, demonstrating that leadership positions are attainable with dedication, expertise, and a commitment to excellence.
IHU Liryc’s Future Under New Leadership
Looking ahead, Dr. Hocini’s strategic vision for IHU Liryc centers on bolstering the institute’s international development and fostering a culture of innovation. She aims to strengthen the institute’s scientific, clinical, and academic trajectory while simultaneously expanding its reach and impact on a global scale. This includes collaborations with international research institutions and the development of cutting-edge technologies to improve the diagnosis and treatment of heart rhythm disorders.
Dr. Hocini has reaffirmed her commitment to maintaining and enhancing the institute’s momentum in research, clinical practice, and academic pursuits. Her leadership is expected to drive further advancements in understanding the complexities of cardiac arrhythmias and translating those discoveries into tangible benefits for patients worldwide.
The institute’s function is particularly relevant given the increasing prevalence of heart rhythm disorders, driven in part by an aging global population and lifestyle factors. IHU Liryc’s research is focused on identifying new therapeutic targets and developing innovative interventions to address these challenges.
The appointment of Dr. Mélèze Hocini represents a new chapter for IHU Liryc, one characterized by strong leadership, a commitment to innovation, and a dedication to improving the lives of individuals affected by heart rhythm disorders. Her vision and expertise are poised to propel the institute to even greater heights in the years to arrive.
The next major milestone for IHU Liryc will be the presentation of its latest research findings at the International Society for Cardiac Electrophysiology (ISCE) annual conference in May 2026. Readers interested in learning more about the institute’s work can visit the IHU Liryc website for updates and information. We encourage readers to share their thoughts and experiences with heart rhythm disorders in the comments below.